CLINICAL_TRIALS
trial_result
· 2019-10-10
Clinical Trial Update: Study of Efficacy and Safety of CJM112 in Patients With Moderate to Severe Inflammatory Acne [Phase 2]
Summary
Phase 2 clinical trial update for CJM112 in moderate to severe inflammatory acne completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED | Results posted: 2019-10-10